Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Johnson & Johnson logoJohnson & Johnson JNJ

The company said Reported Sales for Q2 2025 rose to $23,743 million, up 5.8%, and Net Earnings rose to $5,537 million, up 18.2%. Diluted EPS increased 18.7% to $2.29.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said Reported Sales for Q2 2025 rose to $23,743 million, up 5.8%, and Net Earnings rose to $5,537 million, up 18.2%. Diluted EPS increased 18.7% to $2.29.

  2. The company said Adjusted Net Earnings for Q2 were $6,699 million, -2.1%, and Adjusted EPS (diluted) was $2.77, -1.8%. It estimated Free Cash Flow at about $6,200 million, compared with $7,507 million a year earlier.

  3. In its July 2025 outlook, the company set the midpoint of full-year Estimated Reported Sales at $93.4B (change of 5.4%) and the midpoint of Adjusted EPS (Diluted) at $10.85. Its prior April 2025 outlook midpoints were $91.4B (3.1%) and $10.60, respectively.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

Q2 Sales and Net Earnings

The company said Reported Sales for Q2 2025 rose to $23,743 million, up 5.8%, and Net Earnings rose to $5,537 million, up 18.2%. Diluted EPS increased 18.7% to $2.29.

Source · Based on the filing body and exhibits

Adjusted Metrics and Free Cash Flow

The company said Adjusted Net Earnings for Q2 were $6,699 million, -2.1%, and Adjusted EPS (diluted) was $2.77, -1.8%. It estimated Free Cash Flow at about $6,200 million, compared with $7,507 million a year earlier.

Source · Based on the filing body and exhibits

2025 Full-Year Outlook Change

In its July 2025 outlook, the company set the midpoint of full-year Estimated Reported Sales at $93.4B (change of 5.4%) and the midpoint of Adjusted EPS (Diluted) at $10.85. Its prior April 2025 outlook midpoints were $91.4B (3.1%) and $10.60, respectively.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.